Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis [0.03%]
预测遗传性心肌特里克汀淀粉样变不良预后的因素：来自大规模患者队列的研究
Tomás Ripoll-Vera,Fernando de Frutos,José González-Costello et al.
Tomás Ripoll-Vera et al.
Introduction and objectives: Hereditary transthyretin amyloidosis (hATTR) is a rare, multisystemic, autosomal dominant disease. Cardiac involvement worsens prognosis. We aimed to characterize Spanish patients with hATTR c...
Computed tomography versus cardiac magnetic resonance for myocardial late enhancement quantification [0.03%]
心脏磁共振与心肌延迟强化量化扫描的对比研究
Cristina García-Sebastián,Juan Manuel Monteagudo Ruiz,Sonia Antoñana Ugalde et al.
Cristina García-Sebastián et al.
End-of-life preferences for patients admitted for heart failure. PREFICTER study [0.03%]
心力衰竭患者PREFICTER研究的临终意愿调查
Prado Salamanca Bautista,Carlos Alberto Pazos Amodeo,Alberto Muela Molinero et al.
Prado Salamanca Bautista et al.
Introduction and objectives: Clinical practice guidelines for heart failure (HF) recommend advance care planning and assessment of patients' end-of-life preferences. However, very few studies have captured these preferenc...
Team-based VA-ECMO cardiopulmonary resuscitation: a valuable adjunct in refractory out-of-hospital cardiac arrest [0.03%]
团队为基础的体外膜氧合心肺复苏术在难治性院外心脏骤停中的应用价值
Carlos Roca-Guerrero,Oreste Lanza,Teresa López-Sobrino et al.
Carlos Roca-Guerrero et al.
Transcatheter mitral valve replacement. The beginning of a new era [0.03%]
经导管 MitraClip 戛然作响，缘何重启？——经导管主动脉瓣置换术给经导管二尖瓣治疗带来新希望
Ángel Sánchez-Recalde,Ariana González-Gómez,Covadonga Fernández-Golfín et al.
Ángel Sánchez-Recalde et al.
Influence of sex on surgery of acute type A aortic dissection: mid-term survival and cardiovascular events [0.03%]
急性A型主动脉夹层急诊手术中性别对中期生存率和心血管事件的影响
Yolanda Carrascal,Javier Gómez-Pilar,Rocío Bernal et al.
Yolanda Carrascal et al.
Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial [0.03%]
左心耳闭合术后小剂量直接口服抗凝治疗与双重抗血小板治疗：ADALA试验的1年结果
Eduardo Flores-Umanzor,Ignacio Cruz-González,Pedro Cepas-Guillén et al.
Eduardo Flores-Umanzor et al.
Introduction and objectives: The ADALA trial showed a more favorable efficacy-safety profile with low-dose direct oral anticoagulation (LD-DOAC) vs dual antiplatelet therapy (DAPT) at 3 months after left atrial appendage ...
Prognostic implications of coronary microvascular dysfunction in STEMI with and without metabolic syndrome [0.03%]
代谢综合征存在与缺如的急性ST段抬高型心肌梗死患者中冠状动脉微血管功能障碍的预后意义
Qian Guo,Yingying Guo,Shutian Shi et al.
Qian Guo et al.
Introduction and objectives: Metabolic syndrome (MetS) is associated with coronary microvascular dysfunction (CMD), both of which increase the risk of cardiovascular events after ST-segment elevation myocardial infarction...